Table 1 Baseline and clinical characteristics of the sHTGP patients
Variables | All patients (n = 47) | non-recurrence (n = 24) | recurrence (n = 23) | P |
|---|---|---|---|---|
Age, mean ± SD, y | 37.7 ± 9.6 | 37.2 ± 7.9 | 38.2 ± 11.3 | 0.713 |
Male, n (%) | 32 (68) | 14 (58) | 18 (78) | 0.143 |
BMI, mean ± SD, kg/m2 | 26.9 ± 3.4 | 25.3 ± 4.0 | 27.7 ± 2.7 | 0.338 |
Disease severity, n (%) | 0.897 | |||
Mild | 27 (57.4) | 14 (58.4) | 13 (56.5) | |
Moderate | 9 (19.2) | 5 (20.8) | 4 (17.4) | |
Severe | 11 (23.4) | 5 (20.8) | 6 (26.1) | |
APACHE II, median (ranges) | 8.0 (6.0, 13.0) | 7.5 (6.0, 14.3) | 8.0 (5.5, 14.3) | 0.927 |
SOFA, median (ranges) | 2.0 (1.0, 3.0) | 2.0 (1.0, 3.0) | 2.0 (1.0, 3.0) | 0.981 |
Co-morbidities, n (%) | ||||
Hypertension | 8 (17.0) | 4 (16.7) | 4 (17.4) | 0.947 |
Diabetes | 17 (36.1) | 5 (20.8) | 12 (52.2) | 0.025 |
ICU days, median (ranges) | 3 (2, 7) | 5 (1, 7) | 3 (2, 6) | 0.914 |
Hospital days, median (ranges) | 12 (8, 16) | 14 (9, 16) | 10 (7, 15) | 0.105 |